The company's business prospects have come under a cloud in recent days after the Trump administration said it would close ...
After a series of public market collapses, investors and bankers have strict standards for healthcare startups hoping to IPO ...
Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...
Venture Global Inc.’s belly flop of an IPO isn’t just a setback for the liquefied natural gas-exporting upstart. It may be an ...
Eleganz Interiors IPO opened on February 7, attracting healthy investor interest with a 0.56 times subscription. Retail ...
(Reuters) - Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the ...
Karman Holdings: Another space and defense startup, Karman confidentially filed to go public in January 2025 and aims to ...
Diagnostyka SA’s shares surged in the Polish laboratory operator’s Warsaw debut, signaling a solid start for one of Europe’s ...
The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an analysis here.
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
Readymix Construction Machinery’s IPO launched on February 6, seeking ₹37.66 crore, with shares priced at ₹121-123. The offer ...
Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the United States, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results